Candidemia in COVID-19 treated with corticosteroids and tocilizumab

Koichiro Yamamoto, Kaoru Nakamura, Hideharu Hagiya, Fumio Otsuka

Research output: Contribution to journalArticlepeer-review


COVID-19 patients treated with anti-inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID-19 treatment.

Original languageEnglish
Article numbere04858
JournalClinical Case Reports
Issue number9
Publication statusPublished - Sep 2021


  • SARS-CoV-2
  • candidemia
  • coronavirus disease 2019
  • corticosteroid
  • tocilizumab

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Candidemia in COVID-19 treated with corticosteroids and tocilizumab'. Together they form a unique fingerprint.

Cite this